Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

10 Results Found

Letter/Comment
Public

AHA Urges HHS to Reject the Effort by Several Large Drug Companies to Undermine the 340B Drug Pricing Program

AHA urges Secretary U.S. Department of Health and Human Services to reject the effort by several large drug companies to undermine the 340B Drug Pricing Program by imposing a “rebate model,”
Fact Sheets
Public

Fact Sheet: 340B Drug Pricing Program Contract Pharmacy Arrangements

Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for patients in vulnerable communities. 
Advisory
Member

Trump Administration Issues Order on Drug Pricing

The White House April 15 released an executive order, “Lowering Drug Prices by Once Again Putting Americans First,” directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription drugs.
Advocacy
Public

Affordability Advocacy Agenda

Our shared focus with Congress and Administration is on providing relief from the pandemic, ensuring a smooth recovery, and rebuilding a better health care system for the future. The American Hospital Association continues to incorporate principles that promote improved affordability, value, and equity into our policy and advocacy activities.
Letter/Comment
Public

AHA Letter to Reps. Fischbach and Pence Expressing Support of Congressional Review Act (CRA) Resolutions

AHA writes in support of H.J.Res. 139, a joint resolution for congressional disapproval of a rule relating to "Medicare and Medicaid Programs; Minimum Staffing Standards for Long-Term Care Facilities and Medicaid Institutional Payment Transparency Reporting."
Fact Sheets

Fact Sheet: AHA Priorities for Budget Reconciliation Package to Support America’s Hospitals and Health Systems

It is imperative that Congress invest in America’s hospitals and health systems to ensure that the nation’s health care needs can be met today and into the future. The AHA supports investments in infrastructure, such as the health care workforce, behavioral health, the accessibility and affordability of health care coverage, emergency preparedness and the health care supply chain, telehealth and cybersecurity, among other areas.
Landing Page

Drug Prices

Hospitals bear a heavy financial burden when the cost of drugs increases. They are not only major purchasers of drugs, but patients often end up in the hospital when they cannot afford to take their medications as prescribed. To that end, the American Hospital Association is proud to be a member of the Campaign for Sustainable Rx Pricing -– a diverse coalition of doctors, hospitals, pharmacists, employers, health plans, seniors, patients, consumers and others coming together to find common ground and solutions.
Fact Sheets

Fact Sheet: Advocacy Priorities for Fall 2022

America’s hospitals and health systems continue to deal with the difficult challenges of high inflation and ongoing effects of the COVID-19 pandemic. Specifically, hospitals are facing significant increases in costs of labor from workforce shortages, drugs, equipment and supplies (including food and energy costs) that are threatening their stability and ability to provide access to high quality health care services. The AHA has developed resources that hospital leaders can use to advocate on these important issues.
340B Advocacy Alliance Bulletin
Member

AHA 340B Advocacy Alliance Bulletin: Attorneys general urge HHS to hold responsible drug manufacturers not providing 340B discounts

Attorneys general in 27 states and Washington, D.C., today
340B Advocacy Alliance Bulletin
Member

AHA 340B Advocacy Alliance Bulletin: AHA Letter to HHS on 340B Contract Pharmacy Issue

AHA urges HHS to stop drug companies’ refusal to provide required 340B discounts